Skip to main content
logo
Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada flag Canada · Delayed Price · Currency is CAD
0.1350
+0.0150 (12.50%)
Nov 9, 2026, 4:00 PM EST

Voyageur Pharmaceuticals Financials Overview

Millions CAD. Fiscal year is Dec - Nov.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
0.050.01----
Revenue Growth
360.63%-----
Gross Profit
0-----
Operating Income
-2.61-2.89-1.51-1.22-1.61-1.97
Net Income
-3.16-3.53-1.71-1.4-1.75-2.05
Earnings Per Share
-0.02-0.02-0.01-0.01-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
1.810.270.170.010.040.82
Total Debt
0.040.040.060.040.030.04
Net Cash (Debt)
1.770.230.11-0.030.010.78
Net Cash Growth
95.34%104.70%---98.46%-
Net Cash Per Share
0.010.000.00-0.000.000.01

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
-3.35-2.89-0.3-0.99-1.72-1.65
Capital Expenditures
-0.23-0.27-0.17-0.17-0.28-0.44
Free Cash Flow
-3.58-3.16-0.47-1.17-2-2.09
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Margin
-5122.52%-24758.85%----
Pretax Margin
-6210.22%-30231.56%----
Profit Margin
-6210.22%-30231.56%----
FCF Margin
-7033.50%-27067.31%----

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
604.162443.31----